Furthermore, GSEA demonstrated similarities of upregulated pathways between RUNX1mut lymphoid-BP and CBF-related AML in contrast to NPM1mut-AML, highlighting RUNX1mut-specific transcriptional signature (Supplementary Fig. 5). This evidence concerns the gene CEBPZ and acute myeloid leukemia.